Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$518M |
| 2 |
Procter & Gamble
PG
|
+$413M |
| 3 |
Merck
MRK
|
+$354M |
| 4 |
Amazon
AMZN
|
+$331M |
| 5 |
Hasbro
HAS
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$458M |
| 2 |
CELG
Celgene Corp
CELG
|
+$415M |
| 3 |
Mastercard
MA
|
+$305M |
| 4 |
Intuitive Surgical
ISRG
|
+$304M |
| 5 |
PayPal
PYPL
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.6% |
| 2 | Healthcare | 17.13% |
| 3 | Financials | 11.91% |
| 4 | Industrials | 10.9% |
| 5 | Consumer Discretionary | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZAYO
1151
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $2.26M | ﹤0.01% |
65,220
+18,682
| +40% | +$640K |
|
1152
ICL Group
ICL
$6.65B
| $2.25M | ﹤0.01% |
478,612
-1,509,005
| -76% | -$6.97M |
|
|
HBI
1153
DELISTED
Hanesbrands
HBI
| $2.25M | ﹤0.01% |
151,210
+42,201
| +39% | +$642K |
|
1154
Eagle Materials
EXP
$6.69B
| $2.22M | ﹤0.01% |
+24,444
| New | +$2.24M |
|
1155
Vanguard Value ETF
VTV
$189B
| $2.16M | ﹤0.01% |
18,026
-4,278
| -19% | -$494K |
|
1156
PVH
PVH
$3.87B
| $2.12M | ﹤0.01% |
20,178
-635,778
| -97% | -$60.7M |
|
1157
Park Hotels & Resorts
PK
$3.03B
| $2.1M | ﹤0.01% |
81,213
+7,097
| +10% | +$170K |
|
1158
The Ensign Group
ENSG
$10.4B
| $2.08M | ﹤0.01% |
45,939
-2,838
| -6% | -$120K |
|
|
P
1159
Everpure Inc
P
$24.7B
| $2.06M | ﹤0.01% |
+120,581
| New | +$2.13M |
|
1160
Herbalife
HLF
$1.26B
| $2.06M | ﹤0.01% |
43,260
-85,325
| -66% | -$3.7M |
|
1161
Arrow Electronics
ARW
$10.9B
| $2.05M | ﹤0.01% |
24,201
+6,448
| +36% | +$513K |
|
1162
Open Text
OTEX
$5.73B
| $1.99M | ﹤0.01% |
45,166
+1,125
| +3% | +$47.3K |
|
|
TCO
1163
DELISTED
Taubman Centers Inc.
TCO
| $1.96M | ﹤0.01% |
+63,126
| New | +$2.16M |
|
1164
Warner Bros
WBD
$63.4B
| $1.96M | ﹤0.01% |
59,721
-478,393
| -89% | -$14.4M |
|
1165
ZTO Express
ZTO
$18.1B
| $1.95M | ﹤0.01% |
+83,489
| New | +$1.8M |
|
1166
Afya
AFYA
$1.3B
| $1.91M | ﹤0.01% |
+70,398
| New | +$1.9M |
|
1167
New York Times
NYT
$11.7B
| $1.9M | ﹤0.01% |
59,109
| – | – |
|
1168
Charles River Laboratories
CRL
$10.8B
| $1.89M | ﹤0.01% |
12,399
-20,968
| -63% | -$2.9M |
|
1169
Vanguard High Dividend Yield ETF
VYM
$81.3B
| $1.87M | ﹤0.01% |
19,966
+515
| +3% | +$46.7K |
|
|
CISN
1170
DELISTED
Cision Ltd. Ordinary Share
CISN
| $1.85M | ﹤0.01% |
185,745
-11,257,621
| -98% | -$108M |
|
1171
AGCO
AGCO
$8.71B
| $1.83M | ﹤0.01% |
23,713
-19,704
| -45% | -$1.51M |
|
1172
Sprouts Farmers Market
SFM
$7.23B
| $1.83M | ﹤0.01% |
94,369
-1,311
| -1% | -$25.4K |
|
1173
Qualys
QLYS
$4.75B
| $1.82M | ﹤0.01% |
21,826
+1,771
| +9% | +$147K |
|
1174
QuidelOrtho
QDEL
$1.15B
| $1.81M | ﹤0.01% |
24,173
+1,368
| +6% | +$88.4K |
|
1175
Insight Enterprises
NSIT
$3.71B
| $1.81M | ﹤0.01% |
25,779
+3,875
| +18% | +$244K |
|
Similar funds
Janus Henderson Group's Q4 2019 Portfolio in Review
As of Q4 2019, Janus Henderson Group held 1,494 positions worth $195B, up 5.8% from $185B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Janus Henderson Group's Q4 2019 filing shows 96 new, 553 increased, 735 reduced and 82 closed positions. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 5,875,619 shares worth $213M. The largest sale was Walt Disney, an estimated $458M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q4 2019 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 5,875,619 shares worth $213M.
- Janus Henderson Group added most to Meta Platforms (Facebook) in Q4 2019, an estimated $518M increase.
- Janus Henderson Group's biggest Q4 2019 reduction was Walt Disney, cutting an estimated $458M.
- Janus Henderson Group fully exited Celgene Corp in Q4 2019, selling an estimated $415M.
- Janus Henderson Group's ten largest holdings make up 18% of its $195B portfolio in Q4 2019.
- Janus Henderson Group opened 96 new positions and closed 82 in Q4 2019.
- Janus Henderson Group's portfolio value rose 5.8% quarter-over-quarter to $195B.
Based on Janus Henderson Group's 13F filing for Q4 2019, filed 18 Feb 2020.